Herranz, C., Mateo González, F., Baiges, A., Ruiz de Garibay, G., Junza Martínez, A., Johnson, S. R., . . . Pujana Genestar, M. Á. (2021). Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis.
Citación estilo ChicagoHerranz, Carmen, et al. Histamine Signaling and Metabolism Identify Potential Biomarkers and Therapies for Lymphangioleiomyomatosis. 2021.
Cita MLAHerranz, Carmen, et al. Histamine Signaling and Metabolism Identify Potential Biomarkers and Therapies for Lymphangioleiomyomatosis. 2021.
Precaución: Estas citas no son 100% exactas.